6,534 followers
New research: Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience: Background Ripretinib was recently approved for the fourth-line targeted therapy for advanced… https://t.co/UOBmpI